Tavelli, J. P., Chung, R., Bai, K., Gorroochurn, P., Duong, J., & Anderson, C. B. (2025). The impact of age on BCG treatment response. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2025.02.004

Joffe, B. I., Martina, L. P., Stillman, M., Rust, D., Gorroochurn, P., Lenis, A. T., DeCastro, G. J., McKiernan, J. M., & Anderson, C. B. (2024). Tumor characteristics in immunosuppressed and renal dysfunction populations. Urologic Oncology: Seminars and Original Investigations, 42(12), 453.e9-453.e14. https://doi.org/10.1016/j.urolonc.2024.09.011

Ingram, J. W., Chung, R., Laplaca, C., McKiernan, J. M., Lenis, A. T., & Anderson, C. B. (2024). Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 42(9), 290.e11-290.e16. https://doi.org/10.1016/j.urolonc.2024.04.017

Gore, J. L., Follmer, K., Reynolds, J., Nash, M., Anderson, C. B., Catto, J. W. F., Chamie, K., Daneshmand, S., Dickstein, R., Garg, T., Gilbert, S. M., Guzzo, T. J., Kamat, A. M., Kates, M. R., Lane, B. R., Lotan, Y., Mansour, A. M., Master, V. A., Montgomery, J. S., … Smith, A. B. (2024). Interruptions in bladder cancer care during the COVID-19 public health emergency. Urologic Oncology: Seminars and Original Investigations, 42(4), 116.e17-116.e21. https://doi.org/10.1016/j.urolonc.2023.11.010

Chung, R., Moran, G. W., Movassaghi, M., Pohl, D., Ingram, J., Lenis, A. T., McKiernan, J. M., Anderson, C. B., & Faiena, I. (2023). Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy. Urologic Oncology: Seminars and Original Investigations, 41(8), 356.e11-356.e18. https://doi.org/10.1016/j.urolonc.2023.04.017

Wallace, B. K., Gillespie, A. M., Moran, G. W., Smigelski, M. B., & Anderson, C. B. (2022). Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitis. Urologic Oncology: Seminars and Original Investigations, 40(12), 540.e11-540.e17. https://doi.org/10.1016/j.urolonc.2022.09.006

Chung, R., Moran, G. W., Wang, C., McKiernan, J. M., & Anderson, C. B. (2022). Partial cystectomy: Review of a single center experience from 2004 to 2019. Urologic Oncology: Seminars and Original Investigations, 40(12), 538.e1-538.e5. https://doi.org/10.1016/j.urolonc.2022.09.003

Pohar, K. S., Patel, S., Lotan, Y., Trabulsi, E., Woods, M., Downs, T., Huang, W. C., Jones, J., Taylor, J., O’Donnell, M., Bivalacqua, T. J., DeCastro, J., Steinberg, G., Kamat, A. M., Resnick, M. J., Konety, B., Schoenberg, M., Jones, J. S., & Daneshmand, S. (2022). Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study. Urologic Oncology: Seminars and Original Investigations, 40(8), 382.e1-382.e6. https://doi.org/10.1016/j.urolonc.2022.04.012

Wallace, B. K., Miles, C. H., & Anderson, C. B. (2022). Effects of race and socioeconomic status on treatment for localized renal masses in New York City. Urologic Oncology: Seminars and Original Investigations, 40(2), 65.e19-65.e26. https://doi.org/10.1016/j.urolonc.2021.11.004

Ho, P., Moran, G. W., Wang, V., Li, G., Virk, R. K., McKiernan, J. M., & Anderson, C. B. (2022). The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e11-60.e16. https://doi.org/10.1016/j.urolonc.2021.07.003